Nuformix appoints Dr Chris Blackwell as Non-executive Director

Cambridge, UK - 11th May 2018

Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs today announced that it has appointed Dr Christopher Blackwell as a Non-executive Director.

Download News

Back to all News